Tilray Brands Inc (TLRY)
1.34
+0.03
(+2.29%)
USD |
NASDAQ |
Nov 22, 16:00
1.345
0.00 (0.00%)
After-Hours: 20:00
Tilray Brands Profit Margin (Quarterly): -19.58% for Aug. 31, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| August 31, 2024 | -19.58% |
| May 31, 2024 | -13.81% |
| February 29, 2024 | -49.22% |
| November 30, 2023 | -25.29% |
| August 31, 2023 | -40.42% |
| May 31, 2023 | -75.31% |
| February 28, 2023 | -804.3% |
| November 30, 2022 | -48.19% |
| August 31, 2022 | -47.96% |
| May 31, 2022 | -311.8% |
| February 28, 2022 | 28.44% |
| November 30, 2021 | -0.13% |
| August 31, 2021 | -24.79% |
| May 31, 2021 | 28.36% |
| February 28, 2021 | -220.8% |
| November 30, 2020 | -77.17% |
| August 31, 2020 | -29.23% |
| May 31, 2020 | -99.80% |
| February 29, 2020 | 3.94% |
| November 30, 2019 | -6.57% |
| Date | Value |
|---|---|
| August 31, 2019 | 13.04% |
| May 31, 2019 | -0.52% |
| February 28, 2019 | -147.1% |
| November 30, 2018 | |
| August 31, 2018 | |
| May 31, 2018 | -45.08% |
| February 28, 2018 | |
| November 30, 2017 | 75.91% |
| August 31, 2017 | |
| May 31, 2017 | -50.66% |
| February 28, 2017 | 96.70% |
| November 30, 2016 | 18.08% |
| August 31, 2016 | 20.46% |
| May 31, 2016 | 42.44% |
| February 29, 2016 | 0.14% |
| November 30, 2015 | -21.27% |
| August 31, 2015 | -50.15% |
| May 31, 2015 | -104.3% |
| February 28, 2015 | -6.02K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-804.3%
Minimum
Feb 2023
28.44%
Maximum
Feb 2022
-91.68%
Average
-34.83%
Median
Profit Margin (Quarterly) Benchmarks
| Aurinia Pharmaceuticals Inc | 21.17% |
| Edesa Biotech Inc | -- |
| Lexaria Bioscience Corp | -2.12K% |
| Xenon Pharmaceuticals Inc | -- |
| ESSA Pharma Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -6.23% |
| Return on Assets | -4.96% |
| Return on Invested Capital | -5.56% |
| Gross Profit Margin (Quarterly) | 29.85% |
| Operating Margin (Quarterly) | -14.80% |
| Return on Net Operating Assets | -5.51% |